Wholesale of pharmaceutical and medical goods
RETHINK PHARMA AS
Revenue 2024
NOK 495
Operating profit
NOK −1,000
Equity
NOK −275,000
Incorporated
2021
Share capital
NOK 30,000
Roles
Daglig lederGøran Røstad
Styrets lederGøran Røstad
StyremedlemMadeleine Heggland Røstad
Shareholders
| Name | Stake | Shares | Year |
|---|---|---|---|
| VESTERGAPET AS | 50.0% | 15.000000 | 2025 |
| EFFEIN AS | 50.0% | 15.000000 | 2025 |
Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.